2.88
Absci Corp Aktie (ABSI) Neueste Nachrichten
A Quick Look at Today's Ratings for Absci Corp(ABSI.US), With a Forecast Between $7 to $13 - 富途牛牛
ABSI: Riding the Market Waves of Growth and Decline in 2025 - investchronicle.com
How Absci Corporation stock performs during market volatilityHigh Reward Swing Trades - Newser
Why Absci Corporation stock attracts strong analyst attentionEarly Buy Suggestion - Newser
Absci Corporation (NASDAQ:ABSI) Given Consensus Rating of "Buy" by Analysts - MarketBeat
Morgan Stanley Assumes Coverage on Absci Corporation (ABSI) with $7 Target - MSN
Thinking Of Buying Absci Corp (NASDAQ: ABSI) Stock? Here Is What You Should Know - Stocksregister
Absci appoints Mary Szela to board of directors and grants stock options - Investing.com
Former Abbott executive Mary Szela joins Absci’s board of directors By Investing.com - Investing.com South Africa
Sumitomo Mitsui Trust Group Inc. Raises Stock Holdings in Absci Corporation (NASDAQ:ABSI) - MarketBeat
Absci appoints Mary Szela to board of directors - TipRanks
Absci Appoints Biopharma Leader Mary Szela to Board of Directors - GlobeNewswire
Former Abbott executive Mary Szela joins Absci’s board of directors - Investing.com Australia
Absci stock rating initiated at Overweight by Morgan Stanley - Investing.com Canada
Absci assumed with an Overweight at Morgan Stanley - TipRanks
Absci Corp (ABSI) Stock: A Year of Highs and Lows in the Market - investchronicle.com
Absci (NASDAQ:ABSI) Downgraded to Sell Rating by Wall Street Zen - MarketBeat
Top 5 AI & Digital Biotech Companies (July 2025) - Securities.io
Absci (NASDAQ:ABSI) Stock Rating Lowered by Wall Street Zen - Defense World
Institute for Wealth Management LLC. Trims Holdings in Absci Corporation (NASDAQ:ABSI) - MarketBeat
Absci (NASDAQ:ABSI) Stock Rating Upgraded by Wall Street Zen - Defense World
Absci Corporation (NASDAQ:ABSI) Receives Consensus Recommendation of "Buy" from Analysts - MarketBeat
Millennium Management LLC Sells 1,149,603 Shares of Absci Co. (NASDAQ:ABSI) - MarketBeat
Transcript : Absci Corporation Presents at Goldman Sachs 46th Annual Global Healthcare Conference 2025, Jun-09-2025 08 - marketscreener.com
Two Sigma Investments LP Raises Stock Position in Absci Co. (NASDAQ:ABSI) - MarketBeat
Deutsche Bank AG Purchases 28,073 Shares of Absci Co. (NASDAQ:ABSI) - Defense World
Absci (NASDAQ:ABSI) Rating Lowered to Sell at Wall Street Zen - MarketBeat
AbSci Corp (ABSI) Sees Borrow Rate Increase | ABSI Stock News - GuruFocus
Woodline Partners LP Decreases Position in Absci Co. (NASDAQ:ABSI) - MarketBeat
Northern Trust Corp Has $1.72 Million Stock Holdings in Absci Co. (NASDAQ:ABSI) - Defense World
Brokerages Set Absci Co. (NASDAQ:ABSI) Price Target at $8.40 - MarketBeat
Wall Street Zen Upgrades Absci (NASDAQ:ABSI) to Hold - Defense World
Ameriprise Financial Inc. Sells 23,668 Shares of Absci Co. (NASDAQ:ABSI) - Defense World
AbSci Corp (ABSI): Key Indicator Shows Noticeable Increase | ABSI Stock News - GuruFocus
Catherine Wood's Strategic Acquisition of Absci Corp Shares - GuruFocus
Schonfeld Strategic Advisors LLC Has $144,000 Stake in Absci Co. (NASDAQ:ABSI) - MarketBeat
Absci to Participate in Upcoming Investor Conferences - GlobeNewswire
Absci Sets Stage for Major AI Breakthroughs at Goldman Sachs and Jefferies Healthcare Conferences - Stock Titan
Needham & Company LLC Reiterates Buy Rating for Absci (NASDAQ:ABSI) - MarketBeat
Price T Rowe Associates Inc. MD Increases Holdings in Absci Co. (NASDAQ:ABSI) - Defense World
Absci Co. (NASDAQ:ABSI) Shares Sold by Stifel Financial Corp - Defense World
Needham & Company LLC Reaffirms “Buy” Rating for Absci (NASDAQ:ABSI) - Defense World
Absci Corp’s Earnings Call: A Promising Outlook - TipRanks
Absci Corporation (NASDAQ:ABSI) Q1 2025 Earnings Call Transcript - Insider Monkey
Absci First Quarter 2025 Earnings: Beats Expectations - Yahoo Finance
Dimensional Fund Advisors LP Acquires 241,779 Shares of Absci Co. (NASDAQ:ABSI) - Defense World
ABSI: Needham Reiterates Buy Rating and $9 Price Target | ABSI Stock News - GuruFocus
Absci (ABSI) Initiates Phase 1 Study of AI-Designed Antibody ABS-101 | ABSI Stock News - GuruFocus
Absci (ABSI) Launches First Human Trial for ABS-101 - GuruFocus
ABSI: Needham Reiterates Buy Rating and $9 Price Target | ABSI S - GuruFocus
Assessing Absci: Insights From 6 Financial Analysts - Benzinga
Why Everus Construction Group Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket - Benzinga
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):